文献速递产科母胎医学

妊娠期贫血与孕产妇及围产期不良结局的关联

Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy.
PubMed 文献 · Obstet Gynecol · 2019-01-01

一项基于加拿大不列颠哥伦比亚省2004至2016年515270例孕妇的回顾性队列研究显示,12.8%的孕妇患有贫血,贫血与孕产妇及围产期不良结局相关。

要点

  • 贫血孕妇发生子痫前期、前置胎盘、剖宫产及输血的风险增高。
  • 贫血与早产、小于胎龄儿、低5分钟Apgar评分、新生儿死亡及围产期死亡相关。
  • 贫血严重程度与输血风险呈剂量效应关系。

核心结论

  • 妊娠期贫血是常见的、潜在可逆的危险因素,与产前、产时及产后孕产妇疾病负担及围产期疾病和死亡相关。

研究设计与样本

  • 基于人群的回顾性队列研究,纳入2004至2016年间加拿大不列颠哥伦比亚省所有20周及以上活产或死产的孕妇,共515270例。
  • 贫血诊断基于两个标准:孕晚期血红蛋白值或分娩入院前贫血诊断。
  • 贫血分为无贫血(血红蛋白≥11 g/dL)、轻度(9-10.9 g/dL)、中度(7-8.9 g/dL)、重度(<7 g/dL)及严重程度未明(分娩前诊断)。

主要发现

  • 515270例孕妇中65906例(12.8%)患有贫血:轻度11.8%、中度0.43%、重度0.02%,严重程度未明0.58%。
  • 贫血孕妇住院时间更长、产前入院次数更多,子痫前期、前置胎盘和剖宫产率更高。
  • 无贫血孕妇产时产后输血率为5.1/1000,贫血孕妇输血风险增高:轻度aOR 2.45(95%CI 1.74-3.45),中度aOR 21.3(95%CI 12.2-37.3),重度无法分析,严重程度未明aOR 48.3(95%CI 6.60-353.9)。
  • 贫血与早产相关:轻度aOR 1.09(95%CI 1.05-1.12),中度aOR 2.26(95%CI 2.02-2.54),严重程度未明aOR 2.27(95%CI 2.06-2.50)。
  • 贫血还与小于胎龄儿活产、低5分钟Apgar评分、新生儿死亡及围产期死亡相关。

关键数值与推荐

  • 贫血诊断标准:孕晚期血红蛋白值或分娩入院前贫血诊断。
  • 贫血分级:无贫血血红蛋白≥11 g/dL;轻度9-10.9 g/dL;中度7-8.9 g/dL;重度<7 g/dL。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the incidence of anemia in pregnancy and compare the maternal and perinatal outcomes of women with and without anemia. METHODS: We conducted a population-based retrospective cohort study on all pregnant women in British Columbia who had a live birth or stillbirth at or after 20 weeks of gestation between 2004 and 2016. Women were diagnosed with anemia based on two criteria: third-trimester hemoglobin value or a delivery admission diagnosis of anemia (made before delivery). Anemia was categorized into no anemia (hemoglobin 11 g/dL or greater), mild (9-10.9 g/dL), moderate (7-8.9 g/dL), severe (less than 7 g/dL), or anemia of unspecified severity (with diagnosis made before delivery). Logistic regression was used to estimate adjusted odds ratios (aOR) and 95% CIs expressing the association between anemia and maternal and perinatal outcomes. RESULTS: Of 515,270 women in the study population, 65,906 (12.8%) had anemia: 11.8%, 0.43%, and 0.02% had mild, moderate, and severe anemia, respectively, and 0.58% had anemia of unspecified severity. Anemic women had longer hospitalization duration and more antenatal admissions, and rates of preeclampsia, placenta previa and cesarean delivery were higher among women with anemia. The intrapartum-postpartum blood transfusion rate was 5.1 per 1,000 among women without anemia, and higher among women with anemia (aOR 2.45, 95% CI 1.74-3.45 for mild anemia; 21.3, 95% CI 12.2-37.3 for moderate anemia; not analyzable for severe anemia; and 48.3, 95% CI 6.60-353.9 for anemia of unspecified severity). Anemia was associated with preterm birth (mild anemia, aOR 1.09, 95% CI 1.05-1.12; moderate anemia, aOR 2.26, 95% CI 2.02-2.54; anemia of unspecified severity, aOR 2.27, 95% CI 2.06-2.50), small-for-gestational-age live birth, low 5-minute Apgar score, neonatal death, and perinatal death. CONCLUSION: Maternal anemia in pregnancy represents a common and potentially reversible risk factor associated with antepartum, intrapartum, and postpartum maternal morbidity and perinatal morbidity and mortality.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Smith C, Teng F, Branch E, et al. Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy. Obstet Gynecol. 2019. PMID: 31764734. doi:10.1097/AOG.0000000000003557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。